Hoe verhoudt MPL's PS Ratio zich tot zijn concurrenten?

MPL is een goede waarde op basis van zijn Price-To-Sales Ratio (1.3x) vergeleken met het gemiddelde van gelijken (1.6x).

Hoe verhoudt MPL's PS Ratio zich tot andere bedrijven in de Global Insurance industrie?

MPL is duur op basis van de Price-To-Sales -ratio ( 1.3 x) vergeleken met het Australian Insurance -industriegemiddelde ( 1.2 x).

Wat is MPL's PS Ratio vergeleken met zijn Fair PS Ratio? Dit is de verwachte PS Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

MPL is een goede waarde op basis van de Price-To-Sales -ratio ( 1.3 x) vergeleken met de geschatte eerlijke Price-To-Sales -ratio ( 1.8 x).

Wat is de reële prijs van MPL als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

MPL ( A$3.68 ) wordt verhandeld onder onze schatting van [[eerlijke waarde]] ( A$6.36 )

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

De koersdoelstelling is minder dan 20 % hoger dan de huidige aandelenkoers.

Medibank Private (ASX:MPL) - Aandelenkoers, Nieuws & Analyse

MPL Overzicht aandelen

Medibank Private Limited biedt particuliere ziektekostenverzekeringen en gezondheidsdiensten aan in Australië.

Over het bedrijf

MPL fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	4/6
Prestaties in het verleden	3/6
Financiële gezondheid	5/6
Dividenden	2/6

Beloningen

Verhandeld tegen 42.1% onder onze schatting van de reële waarde

De winst zal naar verwachting met 27.13% per jaar groeien

Risicoanalyse

Dividend van 4.51% wordt niet goed gedekt door de winst

Medibank Private Limited Concurrenten

nib holdings

ASX:NHF

AU$2.9b

Generation Development Group

ASX:GDG

AU$1.0b

ClearView Wealth

ASX:CVW

AU$338.8m

Suncorp Group

ASX:SUN

AU$23.3b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Medibank Private
Historische aandelenkoersen
Huidige aandelenkoers	AU$3.68
52 Week Hoogtepunt	AU$4.01
52 Week Laag	AU$3.40
Bèta	0.20
11 maand verandering	0.55%
3 maanden verandering	-4.66%
1 Jaar Verandering	6.05%
33 jaar verandering	7.60%
5 jaar verandering	16.46%
Verandering sinds IPO	71.96%

Recent nieuws en updates

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Aug 08

Medibank Private Limited's (ASX:MPL) Prospects Need A Boost To Lift Shares

Jun 09

Recent updates

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

Nov 15

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Nov 01

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 09

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Aug 21

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

May 29

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

Feb 27

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Aug 30

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Feb 14

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Jan 19

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Dec 23

Rendement voor aandeelhouders

	MPL	AU Insurance	AU Markt
7D	2.5%	2.0%	0.2%
1Y	6.1%	19.8%	16.6%

Rendement versus industrie: MPL presteerde slechter dan de Australian Insurance -sector, die het afgelopen jaar een rendement van 19.8 % opleverde.

Rendement versus markt: MPL presteerde slechter dan Australian Market, dat het afgelopen jaar een rendement van 16.6 % opleverde.

Prijsvolatiliteit

Is MPL's price volatile compared to industry and market?
MPL volatility
MPL Average Weekly Movement	2.5%
Insurance Industry Average Movement	4.0%
Market Average Movement	8.4%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.5%

Stabiele aandelenkoers: MPL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van MPL is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1976	3,220	David Koczkar	www.medibank.com.au

Medibank Private Limited biedt particuliere ziektekostenverzekeringen en gezondheidsdiensten aan in Australië. Het bedrijf is actief in twee segmenten, Health Insurance en Medibank Health. Het segment Health Insurance biedt particuliere ziektekostenverzekeringsproducten, waaronder ziekenhuisdekking die leden dekking biedt voor ziekenhuisbehandelingen; en aanvullende dekking die leden dekking biedt voor gezondheidsdiensten, zoals tandheelkunde, optiek en fysiotherapie.

Medibank Private Limited Samenvatting

Hoe verhouden de winst en inkomsten van Medibank Private zich tot de beurswaarde?
MPL fundamentele statistieken
Marktkapitalisatie	AU$10.05b
Inkomsten(TTM)	AU$3.90m
Inkomsten(TTM)	AU$8.03b

2,599x

Koers/Winstverhouding

1.3x

P/S-verhouding

Is MPL overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
MPL resultatenrekening (TTM)
Inkomsten	AU$8.03b
Kosten van inkomsten	AU$6.29b
Brutowinst	AU$1.74b
Overige uitgaven	AU$1.74b
Inkomsten	AU$3.90m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.0014
Brutomarge	21.67%
Nettowinstmarge	0.049%
Schuld/Eigen Vermogen Verhouding	1.5%

Hoe presteerde MPL op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

4.5%

Huidig dividendrendement

11,723%

Uitbetalingsratio

MPL Overzicht aandelen

Beloningen

Risicoanalyse

Medibank Private Limited Concurrenten

ASX:NHF

AU$2.9b

ASX:GDG

AU$1.0b

ASX:CVW

AU$338.8m

ASX:SUN

AU$23.3b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings: EPS misses analyst expectations

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited's (ASX:MPL) Prospects Need A Boost To Lift Shares

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings: EPS misses analyst expectations

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited's (ASX:MPL) Prospects Need A Boost To Lift Shares

Here's Why Medibank Private (ASX:MPL) Has Caught The Eye Of Investors

High number of new directors

First half dividend increased to AU$0.072

New major risk - Revenue and earnings growth

First half 2024 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Medibank Private Limited (ASX:MPL) Investors Are Less Pessimistic Than Expected

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued after recent price drop

Price target decreased to AU$3.36

Consensus EPS estimates fall by 10%

Price target decreased to AU$3.45

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought AU$151k worth of stock

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Now 22% undervalued after recent price drop

Upcoming dividend of AU$0.069 per share

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Medibank Private Limited Provides Earnings Guidance for 2022

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

CEO & Director Craig Drummond has left the company

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Earnings beat expectations, revenue disappoints

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

New 90-day low: AU$2.79

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?